New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural Immunity

Mangalakumari Jeyanathan,Yushi Yao,Sam Afkhami,Fiona Smaill,Zhou Xing
DOI: https://doi.org/10.1016/j.it.2018.01.006
IF: 19.709
2018-01-01
Trends in Immunology
Abstract:Despite some major progress made in developing tuberculosis (TB) vaccine strategies, with a dozen novel vaccines currently in the clinical pipeline, the world is still missing an effective TB vaccine. This questions whether any major breakthroughs can be achieved without making a drastic departure from the current strategy, which creates a state of 'near-natural immunity', imitating the natural immunity developed after Mycobacterium tuberculosis (Mtb) infection. Here, we argue instead that mounting evidence suggests an effective strategy ought to induce a state of all-around 'un-natural' immunity comprising trained innate immunity (TII), tissue-resident memory T cells (TRM), and anti-Mtb surface antibodies in the lung. Thus, here we summarize the latest information, thinking, and development in the field of TB and vaccines.
What problem does this paper attempt to address?